Norman David Eansor Bio Techne Corp (TECH) insider trading activity

Norman David Eansor is President-Protein Sciences of BIO-TECHNE Corp. Currently has a direct ownership of 2,117 shares of TECH, which is worth approximately $152,064. The most recent transaction as insider was on Nov 16, 2021, when has been sold 799 shares (Common Stock) at a price of $125.05 per share, resulting in proceeds of $99,915. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.12K

0% 3M change

0% 12M change

Total Value Held $152,064

Norman David Eansor Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 16 2021	BUY Exercise of conversion of derivative security	$99,915 $125.05 p/Share	799 Added 27.4%	2,117 Common Stock
Nov 12 2021	SELL Open market or private sale	$13,697,642 $504.35 p/Share	27,159 Reduced 95.37%	1,318 Common Stock
Nov 12 2021	BUY Exercise of conversion of derivative security	$3,396,233 $125.05 p/Share	27,159 Added 48.82%	28,477 Common Stock
Aug 31 2021	SELL Open market or private sale	$773,722 $503.07 p/Share	1,538 Reduced 53.85%	1,318 Common Stock
Aug 08 2021	SELL Payment of exercise price or tax liability	$481,338 $481.82 p/Share	999 Reduced 25.91%	2,856 Common Stock
Aug 08 2021	BUY Exercise of conversion of derivative security	-	2,537 Added 39.69%	3,855 Common Stock
Feb 05 2021	SELL Open market or private sale	$12,572,173 $381.75 p/Share	32,933 Reduced 96.15%	1,318 Common Stock
Feb 05 2021	BUY Exercise of conversion of derivative security	$3,510,328 $106.59 p/Share	32,933 Added 49.02%	34,251 Common Stock

Also insider at

MRKR

Marker Therapeutics, Inc. Healthcare

Director

NDE